URL | https://www.wsj.com/health/pharma/us-pharmaceutica |
Source | Wall Street Journal |
Date Published | 09/16/2025 |
Author Name | Peter Loftus |
Type of work | Manufacturing |
Reshoring category: | Foreign Direct Investment |
Year reshoring announced: | 2025 |
Domestically, the work will be done: | In-house |
Capital investment ($): | 1200 |
Country(ies) from which reshored: | United Kingdom |
City reshored to: | Philadelphia |
State(s) reshored to: | PA |
If relevant, work nearshored to: | - |
Industry(ies): | Chemicals |
Product(s) reshored | pharmaceuticals |
What non-domestic negative factors made offshoring less attractive? | Supply chain interruption, Tariffs |